Physician profile
Patrick William Commiskey
NPI 1265929244
$1,817.31
in general payments reported to CMS, 2019-2025
13 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $568 · 2023: $339 · 2024: $452 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $558.16 | 2022-2025 | Clareon, Centurion, Unity |
| Johnson & Johnson Surgical Vision, INC. | $355.41 | 2024-2025 | Tecnis Simplicity |
| Glaukos Corporation | $201.40 | 2022-2025 | Idosetr, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Carl Zeiss Meditec, INC. | $146.04 | 2022 | |
| Bausch & Lomb Americas INC. | $139.85 | 2023-2024 | Miebo |
| Sight Sciences, INC. | $134.96 | 2022-2023 | Sion Surgical Instrument, Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $107.83 | 2021 | |
| Allergan, INC. | $47.53 | 2021 | |
| Biotissue Holdings INC. | $33.04 | 2025 | |
| Ivantis, INC | $32.81 | 2021 | |
| Abbvie INC. | $23.83 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $20.19 | 2025 | Calquence |
| Mallinckrodt Hospital Products INC. | $16.26 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Commiskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.